| The Study of Pharmacokinetics and Pharmacodynamics of Huperzine a Injection in Healthy Chinese Subjects | The Study of Pharmacokinetics and Pharmacodynamics of Huperzine a Injection in Healthy Chinese Subjects | NCT06570655 |
| Comparative Bioavailability Study of an Immediate Release and Controlled Release Oral Formulations of Huperzine A | An Open-label, Three-period, Crossover Study in Healthy Volunteers to Evaluate the Relative Bioavailability of Two Different Release Rate Controlled Release Formulations of Huperzine A (0.4mg)Compared to the Equivalent Dose of an Immediate Release Formulation. | NCT01136551 |
| Rivastigmine and Huperzine A as Treatments for Cocaine Dependence | Rivastigmine and Huperzine A as Treatments for Cocaine Dependence | NCT01030692 |
| Effects of Huperzine a on Presbycusis(?,kHz, DB,MMSE, AD) | Effects of Huperzine a on Presbycusis-related Subjective Tinnitus and Cognitive Impairment | NCT03101722 |
| Huperzine A in Alzheimer's Disease | A Multi-Center, Double-Blind, Placebo-Controlled Therapeutic Trial to Determine Whether Natural Huperzine A Improves Cognitive Function | NCT00083590 |
| A randomized, controlled, double-blind, single-center study of huperzine A injection in improving cognitive dysfunction after brain injury | A randomized, controlled, double-blind, single-center study of huperzine A injection in improving cognitive dysfunction after brain injury | ChiCTR2400092753 |
| Evaluation of Three Potential Central Nervous System (CNS) Pretreatments for Soman Exposure on Human Performance | Evaluation of Three Potential CNS Pretreatments for Soman Exposure - Huperzine A, Donepezil, and Galantamine - on Human Performance | NCT01194336 |
| Effect of Huperzine A on Cognitive Function and Perception of Effort During Exercise | Effect of Huperzine A on Cognitive Function and Perception of Effort During Exercise | NCT03445104 |
| The Study of Ginkgo Leaf Dropping Pills and Huperzine a Injection Combined with Median Nerve Electrical Stimulation in the Treatment of Cognitive Impairment After Brain Injury | The Study of Ginkgo Leaf Dropping Pills and Huperzine a Injection Combined with Median Nerve Electrical Stimulation in the Treatment of Cognitive Impairment After Brain Injury | NCT06704334 |
| Huperzine A in combination with quercetin in the treatment of Reversible Cognitive Frailty: a randomized controlled trial | Huperzine A in combination with quercetin in the treatment of Reversible Cognitive Frailty: a randomized controlled trial | ChiCTR1800018048 |
| The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot Study | The Effect of Huperzine A Injection on Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage: a Pilot Study | NCT05560373 |
| A Study of Huperzine A Injection in Reducing Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Surgery | A Multi-center, Randomized, Double-blinded, Placebo-controlled Study of Huperzine A Injection in Reducing Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Surgery | NCT05242419 |
| Clinical Study of Huperzine A in the Treatment of Patients With Hypertensive Cerebral Hemorrhage | A Randomized, Controlled, Single-center Clinical Study of Huperzine A in the Treatment of Brain Injury in Patients With Hypertensive Cerebral Hemorrhage | NCT04509323 |
| Clinical study on the efficacy and safety of Huperzine A injection in protecting cerebral function in patients with cerebral infarction | Clinical study on the efficacy and safety of Huperzine A injection in protecting cerebral function in patients with cerebral infarction | ChiCTR2000034554 |
| Effects of Huperzine A in Treatment of Moderate to Severe TBI | Huperzine A for the Treatment of Cognitive, Mood, and Functional Deficits After Moderate and Severe TBI | NCT01676311 |
| Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease | A Multi-Center, Randomized, Double-Blind, Double-Dummy, Placebo- and Active-Controlled, Study to Evaluate the Safety and Efficacy of Huperzine A Sustained-Release Tablets in Patients With Mild to Moderate Alzheimer's Disease | NCT01282619 |
